Intellectual Property India Publishes Patent Application for 'Methods And Devices For Hormone Replacement Therapy' Filed by Dare Bioscience, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517063127 A) filed by Dare Bioscience, Inc., San Diego, on July 2, for 'methods and devices for hormone replacement therapy.'

Inventor(s) include Friend, David; Mauck, Christine; and Zack, Nadene.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "A drug delivery device for use in the treatment of one or more symptoms of menopause in a subject, comprising intravaginally inserting the implantable drug delivery device to the subject, wherein the implantable drug delivery device comprises an estrogen and a progestin, and further wherein the implantable drug delivery device provides a baseline-adjusted steady state plasma estrogen concentration between about 15 pg/mL and about 50 pg/mL in the subject."

The patent application was internationally filed on Jan. 08, 2024, under International application No.PCT/US2024/010729.

Disclaimer: Curated by HT Syndication.